Neurological Issues and Cannabis

In the world of endocannabinoid science, there are 3 areas of large response that are getting attention. Those are autoimmune disorders, cancers, and neurological diseases. Preclinical (in vivo or in vitro) research is exploding in these areas, and some cannabinoid based therapies have even passed FDA Approval for Dravet and Lennox-Gateaux Syndrome. Since many areas are relaxing restrictions on therapeutic access to cannabis, patients and their family members have the option of finding cheaper and more comprehensive alternatives to these FDA approved products. Below are some of the studies regarding cannabinoids and individual neurological disorders.

This is not intended as medical advice or legal advice. Please take these to your medical team so you can make educated and informed decisions.

Autism

Hemiplegic Migraine

Parkinson’s

CB₁ cannabinoid receptor signaling in Parkinson’s disease

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson’s disease: Importance of antioxidant and cannabinoid receptor-independent properties

Cannabinoids reduce levodopa-induced dyskinesia in Parkinson’s disease: A pilot study